The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Adeno-Associated Virus Type 2 Capsids with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and Are Maintained until Uncoating Occurs in the Nucleus
Open accessAbstract
Common features of parvovirus capsids are open pores at the fivefold symmetry axes that traverse the virion shell. Upon limited heat treatment in vitro, the pores can function as portals to externalize VP1/VP2 protein N-terminal sequences which harbor infection-relevant functional domains, such as a phospholipase A 2 catalytic domain. Here we show that adeno-associated virus type 2 (AAV2) also exposes its VP1/VP2 N termini in vivo during infection, presumably in the endosomal compartment. This conformational change is influenced by treatment with lysosomotropic reagents. While incubation of cells with bafilomycin A1 reduced exposure of VP1/VP2 N termini, incubation with chloroquine stimulated externalization transiently. N-terminally located basic amino acid clusters with nuclear localization activity also become exposed in this process and are accessible on the virus capsid when it enters the cytoplasm. This is an obligatory step in AAV2 infection. However, a direct role of these sequences in nuclear translocation of viral capsids could not be determined by microinjection of wild-type or mutant viruses. This suggests that further modifications of the capsid have to take place in a precytoplasmic entry step that prepares the virus for nuclear entry. Microinjection of several capsid-specific antibodies into the cell nucleus blocked AAV2 infection completely, supporting the conclusion that AAV2 capsids bring the infectious genome into the nucleus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Munoz, C., Elvira, B., Towhid, S. T., Alesutan, I., Shumilina, E., Bock, C.-T., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350083 · Cited by 8,675
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Bowman, E. J., Siebers, A., & Altendorf, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7972 · Cited by 1,784
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Marsh, M., & Helenius, A. (2006) · Cell · doi:10.1016/j.cell.2006.02.007 · Cited by 1,186
Nucleocytoplasmic transport: the soluble phase
Mattaj, I. W., & Englmeier, L. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.265 · Cited by 1,175
Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus
Seisenberger, G., Ried, M. U., Endreß, T., Büning, H., Hallek, M., & Bräuchle, C. (2001) · Science · doi:10.1126/science.1064103 · Cited by 820
How Viruses Enter Animal Cells
Smith, A. E., & Helenius, A. (2004) · Science · doi:10.1126/science.1094823 · Cited by 734
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Self-citationThe atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612
pH-dependent regulation of lysosomal calcium in macrophages
Christensen, K. A., Myers, J. T., & Swanson, J. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.599 · Cited by 534
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
Bartlett, J. S., Wilcher, R., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2777-2785.2000 · Cited by 532 · cited 5×
“Although nuclear localization of AAV2 capsids has been described several times (2, 29, 55, 57, 73), there exists some controversy as to the efficiency of this process.”
BackgroundInfluentialA Viral Phospholipase A2 Is Required for Parvovirus Infectivity
Zádori, Z., Szelei, J., Lacoste, M.-C., Li, Y., Gariépy, S., Raymond, P., Allaire, M., Nabi, I. R., & Tijssen, P. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00031-4 · Cited by 518
SEGLEN, P. O., GRINDE, B., & SOLHEIM, A. E. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb12956.x · Cited by 469
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Grieger, J. C., & Samulski, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9933-9944.2005 · Cited by 419
Vacuolar ATPase activity is required for endosomal carrier vesicle formation.
Clague, M. J., Urbé, S., Aniento, F., & Gruenberg, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42302-7 · Cited by 416
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8317 · Cited by 391
Wu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T., & Muzyczka, N. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8635-8647.2000 · Cited by 390
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
Kern, A., Schmidt, K., Leder, C., Müller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., & Kleinschmidt, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11072-11081.2003 · Cited by 380
Self-citationOpie, S. R., Warrington, Agbandje-McKenna, M., Zolotukhin, S., & Muzyczka, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6995-7006.2003 · Cited by 364
Girod, A., Wobus, C. E., Zádori, Z., Ried, M., Leike, K., Tijssen, P., Kleinschmidt, J. A., & Hallek, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-973 · Cited by 354
Self-citationvan Weert, A. W., Dunn, K. W., Gueze, H. J., Maxfield, F. R., & Stoorvogel, W. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.4.821 · Cited by 335
Bayer, N., Schober, D., Prchla, E., Murphy, R. F., Blaas, D., & Fuchs, R. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9645-9655.1998 · Cited by 329
Douar, A.-M., Poulard, K., Stockholm, D., & Danos, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1824-1833.2001 · Cited by 282
Wobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 14×
“In this study we intended to analyze the activation and function of the PLA and the three BC elements located on the VP1 and VP2 N termini during AAV2 infection.”
BackgroundMethodInfluentialSelf-citationSanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T., & Engelhardt, J. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9184-9196.2000 · Cited by 269
Cloning of infectious adeno-associated virus genomes in bacterial plasmids
Laughlin, C. A., Tratschin, J.-D., Coon, H., & Carter, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90217-2 · Cited by 266
Intracellular trafficking of adeno-associated viral vectors
Ding, W., Zhang, L., Yan, Z., & Engelhardt, J. F. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302527 · Cited by 251
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246 · cited 1×
“Infection of cultured cells by adeno-associated virus type 2 (AAV2) is initiated by binding to heparan sulfate proteoglycan as an attachment receptor followed by interaction with either human fibroblast growth factor receptor 1, integrin V 5, or hepatocyte growth factor receptor (35, 50, 62, 63).”
BackgroundYan, Z., Zak, R., Luxton, G. W. G., Ritchie, T. C., Bantel-Schaal, U., & Engelhardt, J. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2043-2053.2002 · Cited by 222
Subcellular compartmentalization of adeno-associated virus type 2 assembly
Wistuba, A., Kern, A., Weger, S., Grimm, D., & Kleinschmidt, J. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1341-1352.1997 · Cited by 219
Self-citationBleker, S., Sonntag, F., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2528-2540.2005 · Cited by 200 · cited 7×
“Genetic and structural data suggest that the N termini of the three capsid proteins—including the VP1 and VP2 N termini— are located at the twofold symmetry axes inside the capsid and traverse through the pores at the fivefold symmetry axes upon heat treatment (5, 37).”
BackgroundMethodInfluentialSelf-citationKronenberg, S., Böttcher, B., von der Lieth, C. W., Bleker, S., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5296-5303.2005 · Cited by 198
Self-citationGrimm, D., Kern, A., Pawlita, M., Ferrari, F. K., Samulski, R. J., & Kleinschmidt, J. A. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300946 · Cited by 195
Self-citationLux, K., Goerlitz, N., Schlemminger, S., Perabò, L., Goldnau, D., Endell, J., Leike, K., Kofler, D. M., Finke, S., Hallek, M. J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11776-11787.2005 · Cited by 186
Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection
Duan, D., Li, Q., Kao, A. W., Yue, Y., Pessin, J. E., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10371-10376.1999 · Cited by 186
Farr, G. A., Zhang, L.-G., & Tattersall, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508477102 · Cited by 184
Vihinen‐Ranta, M., Wang, D., Weichert, W. S., & Parrish, C. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.4.1884-1891.2002 · Cited by 180
Grieger, J. C., Snowdy, S., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.02723-05 · Cited by 172 · cited 1×
“Very recently, further evidence has been presented that BC3 acts in nuclear transport of AAV genomes, based on a difference in nuclear accumulation of recombinant AAV genomes packaged into wt or BC3 mutant capsids shown by in situ hybridization (24).”
BackgroundAdenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2
Xiao, W. S., Warrington, K. H., Hearing, P., Hughes, J. A., & Muzyczka, N. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11505-11517.2002 · Cited by 171
Bafilomycin A1 Treatment Retards Transferrin Receptor Recycling More than Bulk Membrane Recycling
Presley, J. F., Mayor, S., McGraw, T. E., Dunn, K. W., & Maxfield, F. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13929 · Cited by 166
Becerra, S. P., Koczot, F., Fabisch, P., & Rose, J. A. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2745-2754.1988 · Cited by 163
Electron cryo‐microscopy and image reconstruction of adeno‐associated virus type 2 empty capsids
Kronenberg, S., Kleinschmidt, J. A., & Böttcher, B. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve234 · Cited by 161
Self-citationHansen, J. J., Qing, K., Kwon, H., Mah, C. S., & Srivastava, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.992-996.2000 · Cited by 158
Wistuba, A., Weger, S., Kern, A., & Kleinschmidt, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5311-5319.1995 · Cited by 147 · cited 2×
“proteins, respectively, were used as described previously (70).”
BackgroundMethodSelf-citationBantel‐Schaal, U., Hub, B., & Kartenbeck, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2340-2349.2002 · Cited by 144
Sieczkarski, S. B., & Whittaker, G. R. (2005) · Springer eBooks · doi:10.1007/3-540-26764-6_1 · Cited by 144
Yan, Z., Zak, R., Zhang, Y., Ding, W., Godwin, S., Munson, K., Peluso, R., & Engelhardt, J. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2863-2874.2004 · Cited by 138 · cited 1×
“Proteasome inhibitors significantly increase gene transduction with AAV2 (12, 14, 16, 23, 34, 75, 76); however, the mechanism of inhibitor action remains unclear,”
BackgroundExploitation of Microtubule Cytoskeleton and Dynein during Parvoviral Traffic toward the Nucleus
Suikkanen, S., Aaltonen, T. M., Nevalainen, M., Välilehto, O., Lindholm, L., Vuento, M., & Vihinen‐Ranta, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10270-10279.2003 · Cited by 134
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification
Heilbronn, R., Bürkle, A., Stephan, S., & Hausen, H. Z. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.3012-3018.1990 · Cited by 132
Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein
Trempe, J. P., & Carter, B. J. (1988) · Journal of Virology · doi:10.1128/jvi.62.9.3356-3363.1988 · Cited by 131
Hansen, J., Qing, K., & Srivastava, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4080-4090.2001 · Cited by 129 · cited 1×
“3A) in accordance with previous publications (14, 28, 47).”
ResultAdeno-Associated Virus Type 2 Protein Interactions: Formation of Pre-Encapsidation Complexes
Dubielzig, R., King, J., Weger, S., Kern, A., & Kleinschmidt, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.8989-8998.1999 · Cited by 127
Self-citationMani, B., Baltzer, C., Valle, N., Almendral, J. M., Kempf, C., & Ros, C. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.1015-1024.2006 · Cited by 126
Pajusola, K., Gruchała, M., Joch, H., Lüscher, T. F., Ylä‐Herttuala, S., & Büeler, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11530-11540.2002 · Cited by 124
Interfacial Enzymology of Parvovirus Phospholipases A2
Canaan, S., Zádori, Z., Ghomashchi, F., Bollinger, J., Sadílek, M., Moreau, M. E., Tijssen, P., & Gelb, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312630200 · Cited by 122
Cotmore, S. F., D’Abramo, A., Ticknor, C. M., & Tattersall, P. J. (1999) · Virology · doi:10.1006/viro.1998.9520 · Cited by 121
Hauck, B., Zhao, W., High, K. A., & Xiao, W. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13678-13686.2004 · Cited by 117
Lombardo, E., Ramírez, J. C., García‐Pérez, J., & Almendral, J. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7049-7059.2002 · Cited by 115
Release of canine parvovirus from endocytic vesicles
Suikkanen, S., Antila, M., Jaatinen, A., Vihinen-Ranta, M., & Vuento, M. (2003) · Virology · doi:10.1016/j.virol.2003.08.031 · Cited by 115
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
Rosenfeld, S. J., Yoshimoto, K., Kajigaya, S., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115812 · Cited by 108
Infection of Purified Nuclei by Adeno-associated Virus 2
Hansen, J. J., Qing, K., & Srivastava, A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0457 · Cited by 102
Reguera, J., Carreira, A., Riolobos, L., Almendral, J. M., & Mateu, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307748101 · Cited by 90
Farr, G. A., Cotmore, S. F., & Tattersall, P. J. (2005) · Journal of Virology · doi:10.1128/jvi.80.1.161-171.2006 · Cited by 77
Cassinotti, P., Weitzand, M., & Tratschin, J.-D. (1988) · Virology · doi:10.1016/0042-6822(88)90067-0 · Cited by 75
Ding, W., Yan, Z., Žák, R., Saavedra, M. T., Rodman, D. M., & Engelhardt, J. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7361-7366.2003 · Cited by 72
Ros, C., Baltzer, C., Mani, B., & Kempf, C. (2005) · Virology · doi:10.1016/j.virol.2005.09.030 · Cited by 72
Farr, G. A., & Tattersall, P. J. (2004) · Virology · doi:10.1016/j.virol.2004.03.006 · Cited by 72
Vihinen‐Ranta, M., Yuan, W., & Parrish, C. R. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4853-4859.2000 · Cited by 72
Hoque, M., Ishizu, K., Matsumoto, A., Han, S., Arisaka, F., Takayama, M., Suzuki, K., Kenzo, K. A. T. O., Kanda, T., Watanabe, H., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7912-7915.1999 · Cited by 69
Ros, C., & Kempf, C. (2004) · Virology · doi:10.1016/j.virol.2004.04.016 · Cited by 65
Jennings, K., Miyamae, T., Traister, R. S., Marinov, A. D., Katakura, S., Sowders, D. P., Trapnell, B. C., Wilson, J. M., Gao, G., & Hirsch, R. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.10.020 · Cited by 64
Intracellular Route of Canine Parvovirus Entry
Vihinen‐Ranta, M., Kalela, A., Mäkinen, P., Kakkola, L., Marjomäki, V., & Vuento, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.802-806.1998 · Cited by 63
Nuclear Import in Viral Infections
Greber, U. F., & Fornerod, M. W. J. (2005) · Springer eBooks · doi:10.1007/3-540-26764-6_4 · Cited by 40
[24] Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors
Potter, M., Chesnut, K. A., Muzyczka, N., Flotte, T. R., & Zolotukhin, S. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)46069-7 · Cited by 37
Harada, M., Shakado, S., Sakisaka, S., Tamaki, S., Ohishi, M., Sasatomi, K., Koga, H., Sata, M., & Tanikawa, K. (1997) · Liver International · doi:10.1111/j.1600-0676.1997.tb01025.x · Cited by 34
Cited by
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
Grimm, D., Lee, J. S., Wang, L., Desai, T., Akache, B., Storm, T. A., & Kay, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.00254-08 · Cited by 696
Qiu, J., Söderlund-Venermo, M., & Young, N. S. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-16 · Cited by 407
Metadata
- Authors
- Sonntag, F., Bleker, S., Leuchs, B., Fischer, R., & Kleinschmidt, J. A.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-11
- Volume
- 80
- Issue
- 22
- Pages
- 11040-11054
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2009455163
- Cited by
- 280
- References
- 79
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.